Edges in Network
Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | CRLF3 |
Upstream (Parents) |
---|
(<<) ADCY7 → CRLF3 |
(<<) ATP2C2 → CRLF3 |
(<<) CASP1 → CRLF3 |
(<<) CASP10 → CRLF3 |
(<<) CD274 → CRLF3 |
(<<) HLA-F → CRLF3 |
(<<) HRAS → CRLF3 |
(<<) ITGB7 → CRLF3 |
(<<) LAMB2 → CRLF3 |
(<<) LRRC8C → CRLF3 |
(<<) MLKL → CRLF3 |
(<<) NR3C1 → CRLF3 |
(<<) PLCG2 → CRLF3 |
(<<) PPP3CC → CRLF3 |
(<<) PRKCQ → CRLF3 |
(<<) ZBED2 → CRLF3 |
Downstream (Children) |
---|
CRLF3 → BCAR3 (>>) |
CRLF3 → DDR1 (>>) |
CRLF3 → EPHB4 (>>) |
CRLF3 → ETS1 (>>) |
CRLF3 → FAM129B (>>) |
CRLF3 → ICAM2 (>>) |
CRLF3 → LCP1 (>>) |
CRLF3 → MAP2K1 (>>) |
CRLF3 → PLD1 (>>) |
CRLF3 → RAD51L3 (>>) |
CRLF3 → SH2D2A (>>) |
CRLF3 → SMAD1 (>>) |
CRLF3 → STAT5A (>>) |
CRLF3 → ZNF215 (>>) |